Improvement in circulation and in cardiovascular risk factors with a proprietary isotonic bioflavonoid formula OPC-3®

被引:5
作者
Cesarone, Maria R. [2 ]
Di Renzo, Andrea [2 ]
Errichi, Silvia
Schonlau, Frank [3 ]
Wilmer, James L. [1 ]
Blumenfeld, Julian [1 ]
机构
[1] NutraMetrix, Div Market Amer, Greensboro, NC 27409 USA
[2] Univ G dAnnunzio, Dept Biomed Sci, Pescara, Italy
[3] Horphag Res UK, London, England
关键词
bioflavonoid; OPC-3; metabolic syndrome; isotonic; cardiovascular risk factors; pycnogenol;
D O I
10.1177/0003319708321801
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
This study investigated the efficacy of isotonic bioflavonoid Supplementation, OPC-3 on 61 individuals presenting with risk factors meeting the criteria for metabolic syndrome. Subjects were supplemented with a proprietary isotonic bioflavonoid OPC-3 or placebo over 2 months. Plasma oxidative stress status was significantly lowered by 10.1% with OPC-3. All major cardiovascular risk factors were improved with blood pressure, total cholesterol, and Fasting blood glucose lowered. OPC-3 significantly improved endothelial function as evaluated by increased vasorelaxation in reactive hyperemia and enhanced diastolic carotid artery flow. Cardiac ultrasound scanning revealed a significant increase of left ventricular ejection fraction. Skin microcirculation was enhanced, and better tissue perfusion led to significantly increased transcutaneous Oxygen partial pressure and decreased pCO(2). With OPC-3 a dramatic and significant plasma C-reactive protein decrease by 52.1% occurred. Individuals may improve key cardiovascular risk Factors by daily Supplementation with the bioflavonoid OPC-3 as an important part of a healthier lifestyle.
引用
收藏
页码:408 / 414
页数:7
相关论文
共 25 条
[1]  
[Anonymous], 2001, Altern Med Rev, V6, P500
[2]  
[Anonymous], 2005, ENCY DIETARY SUPPLEM
[3]   Prevention of venous thrombosis and thrombophlebitis in long-haul flights with Pycnogenol® [J].
Belcaro, G ;
Cesarone, R ;
Rohdewald, P ;
Ricci, A ;
Ippolito, E ;
Dugall, M ;
Griffin, M ;
Ruffini, I ;
Acerbi, G ;
Vinciguerra, MG ;
Bavera, P ;
Di Renzo, A ;
Errichi, BM ;
Cerritelli, F .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2004, 10 (04) :373-377
[4]   Comparison of Pycnogenol® and Daflon® in treating chronic venous insufficiency:: A prospective, controlled study [J].
Cesarone, M. R. ;
Belcaro, G. ;
Rohdewald, P. ;
Pellegrini, L. ;
Ledda, A. ;
Vinciguerra, G. ;
Ricci, A. ;
Gizzi, G. ;
Ippolito, E. ;
Fano, F. ;
Dugall, M. ;
Acerbi, G. ;
Cacchio, M. ;
Di Renzo, A. ;
Hosoi, M. ;
Stuard, S. ;
Corsi, M. .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (02) :205-212
[5]  
Cheynier V, 2005, AM J CLIN NUTR, V81, p223S, DOI 10.1093/ajcn/81.1.223S
[6]   Diet-derived Phenols in plasma and tissues and their implications for health [J].
Clifford, MN .
PLANTA MEDICA, 2004, 70 (12) :1103-1114
[7]   Chemistry and pharmacology of the Citrus bioflavonoid hesperidin [J].
Garg, A ;
Garg, S ;
Zaneveld, LJD ;
Singla, AK .
PHYTOTHERAPY RESEARCH, 2001, 15 (08) :655-669
[8]   Oxidative stress induced in pathologies:: the role of antioxidants [J].
Gaté, L ;
Paul, J ;
Ba, GN ;
Tew, KD ;
Tapiero, H .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (04) :169-180
[9]   Inhibition of NF-κB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol) [J].
Grimm T. ;
Chovanová Z. ;
Muchová J. ;
Sumegová K. ;
Liptáková A. ;
Ďuračková Z. ;
Högger P. .
Journal of Inflammation, 3 (1)
[10]   Daily aerobic exercise improves reactive hyperemia in patients with essential hypertension [J].
Higashi, Y ;
Sasaki, S ;
Sasaki, N ;
Nakagawa, K ;
Ueda, T ;
Yoshimizu, A ;
Kurisu, S ;
Matsuura, H ;
Kajiyama, G ;
Oshima, T .
HYPERTENSION, 1999, 33 (01) :591-597